Direct-to-Pharmacy
Classical distribution methods of pharmaceutical and medical products via wholesalers can no longer keep up with some of the high and specialised demands of the pharmaceutical industry. We have long recognised the need to optimise the supply chain and continually increase its efficiency. Dynamic market changes have led many of our clients to rethink and strategically reconsider the storage and distribution of their specialised products. In order to smooth out the issues that manufacturers in the healthcare industry have with the delivery of these specialised niche products and biotech products, Movianto has introduced the “Direct-to-Pharmacy” model.
This complementary model ensures that specialised products are delivered cost-efficiently and flexibly. An example illustrating how this service can work for clients, is the logistics and distribution of specialised cancer drugs.
Movianto takes over the distribution of new cancer drug from Celgene in Germany directly supplying pharmacies and hospitals
Direct-to-Pharmacy - Movianto Germany (455 KB)
